Works in Cancer Communications, 2025, Vol 45, Issue 6

Results: 12
    1
    2
    3

    Comprehensive DSRCT multi‐omics analyses unveil CACNA2D2 as a diagnostic hallmark and super‐enhancer‐driven EWSR1::WT1 signature gene.

    Published in:
    Cancer Communications, 2025, v. 45, n. 6, p. 702, doi. 10.1002/cac2.70015
    By:
    • Geyer, Florian Henning;
    • Ritter, Alina;
    • Kinn‐Gurzo, Seneca;
    • Faehling, Tobias;
    • Li, Jing;
    • Jarosch, Armin;
    • Ngo, Carine;
    • Vinca, Endrit;
    • Aljakouch, Karim;
    • Orynbek, Azhar;
    • Ohmura, Shunya;
    • Kirchner, Thomas;
    • Imle, Roland;
    • Romero‐Pérez, Laura;
    • Díaz‐Martín, Juan;
    • Bertram, Stefanie;
    • de Álava, Enrique;
    • Henon, Clémence;
    • Postel‐Vilnay, Sophie;
    • Banito, Ana
    Publication type:
    Article
    4

    Older adults living with gastrointestinal cancers in 2021.

    Published in:
    Cancer Communications, 2025, v. 45, n. 6, p. 658, doi. 10.1002/cac2.70014
    By:
    • Danpanichkul, Pojsakorn;
    • Pang, Yanfang;
    • Inkongngam, Torlap;
    • Namsathimaphorn, Kornnatthanai;
    • Rakwong, Krittameth;
    • Kaeosri, Chuthathip;
    • Nah, Benjamin;
    • Duangsonk, Kwanjit;
    • Tang, Nicole Shu Ying;
    • Mittal, Neha;
    • Kim, Donghee;
    • Noureddin, Mazen;
    • Wallace, Michael B.;
    • Singal, Amit G.;
    • Wijarnpreecha, Karn;
    • Yang, Ju Dong
    Publication type:
    Article
    5
    6

    Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.

    Published in:
    Cancer Communications, 2025, v. 45, n. 6, p. 663, doi. 10.1002/cac2.70012
    By:
    • Mariniello, Katia;
    • Pittaway, James F. H.;
    • Altieri, Barbara;
    • Borges, Kleiton Silva;
    • Hadjidemetriou, Irene;
    • Ribeiro, Claudio;
    • Ruiz‐Babot, Gerard;
    • Tourigny, David S.;
    • Lim, Jiang A.;
    • Foster, Julie;
    • Cleaver, Julie;
    • Sosabowski, Jane;
    • Rahman, Nafis;
    • Doroszko, Milena;
    • Hantel, Constanze;
    • Sigala, Sandra;
    • Abate, Andrea;
    • Tamburello, Mariangela;
    • Kiseljak‐Vassiliades, Katja;
    • Wierman, Margaret
    Publication type:
    Article
    7
    8
    9

    An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial.

    Published in:
    Cancer Communications, 2025, v. 45, n. 6, p. 640, doi. 10.1002/cac2.70009
    By:
    • Wang, Jiayu;
    • Zhang, Qingyuan;
    • Sun, Tao;
    • Li, Huiping;
    • Cheng, Ying;
    • Tong, Zhongsheng;
    • Li, Huihui;
    • Li, Wei;
    • Wang, Jingfen;
    • Teng, Yuee;
    • Wu, Xinhong;
    • Cheng, Jing;
    • Chen, Zhendong;
    • Zhu, Zhengqiu;
    • Wang, Li;
    • Liu, Mingming;
    • Duan, Xianghui;
    • Xu, Lingmei;
    • Xu, Binghe
    Publication type:
    Article
    10
    11

    Cover Image, Volume 45, Issue 6.

    Published in:
    Cancer Communications, 2025, v. 45, n. 6, p. 1, doi. 10.1002/cac2.12561
    By:
    • Mariniello, Katia;
    • Pittaway, James F. H.;
    • Altieri, Barbara;
    • Borges, Kleiton Silva;
    • Hadjidemetriou, Irene;
    • Ribeiro, Claudio;
    • Ruiz‐Babot, Gerard;
    • Tourigny, David S.;
    • Lim, Jiang A.;
    • Foster, Julie;
    • Cleaver, Julie;
    • Sosabowski, Jane;
    • Rahman, Nafis;
    • Doroszko, Milena;
    • Hantel, Constanze;
    • Sigala, Sandra;
    • Abate, Andrea;
    • Tamburello, Mariangela;
    • Kiseljak‐Vassiliades, Katja;
    • Wierman, Margaret
    Publication type:
    Article
    12

    Issue Information.

    Published in:
    Cancer Communications, 2025, v. 45, n. 6, p. 637, doi. 10.1002/cac2.12560
    Publication type:
    Article